Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer
about
Gastrointestinal (GI) leiomyosarcoma (LMS) case series and review on diagnosis, management, and prognosis.Frequent alterations of homologous recombination repair pathway in primary and chemotolerant breast carcinomas: clinical importance.Prediction of therapy response in ovarian cancer: Where are we now?
P2860
Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Molecular cytogenetics as a cl ...... newly diagnosed ovarian cancer
@ast
Molecular cytogenetics as a cl ...... newly diagnosed ovarian cancer
@en
type
label
Molecular cytogenetics as a cl ...... newly diagnosed ovarian cancer
@ast
Molecular cytogenetics as a cl ...... newly diagnosed ovarian cancer
@en
prefLabel
Molecular cytogenetics as a cl ...... newly diagnosed ovarian cancer
@ast
Molecular cytogenetics as a cl ...... newly diagnosed ovarian cancer
@en
P2093
P2860
P356
P1476
Molecular cytogenetics as a cl ...... newly diagnosed ovarian cancer
@en
P2093
Amita Patnaik
Andres Barrera
Anthony Tolcher
Brianne Kaiser
Chris McCaskill
Dale Taylor
Jaeweon Kim
Korrie Weldon
Mansoor Mohammed
Mariam Ishaque
P2860
P2888
P356
10.1186/1757-2215-6-2
P577
2013-01-04T00:00:00Z
P5875
P6179
1024178625